Companies / NeuroPace Inc
NeuroPace Inc
Financials · FY2025
Ownership
34.3M shares outstanding · as of Aug 7, 2026
Ownership
| Insiders | 2.32% | 795,416 |
| Institutions | 76.76% | 26,348,297 |
| Public float | 20.92% | 7,180,561 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 7
View all →| Insider | % of shares | Shares |
|---|---|---|
Fischer Frank MDirector | 1.75% | 599,534 |
Becker JoelCEOCHIEF EXECUTIVE OFFICER · Director | 0.28% | 96,937 |
Morrell MarthaCHIEF MEDICAL OFFICER | 0.14% | 47,283 |
Kumar RakhiDirector | 0.06% | 19,160 |
Geiger UriDirector | 0.04% | 14,858 |
Lacob JosephDirector | 0.04% | 14,754 |
Huennekens R ScottDirector | <0.01% | 2,890 |
Institutional holders 106
View all →| Holder | Value | % of shares |
|---|---|---|
| $44.44M | 8.39% | |
| $41.74M | 7.88% | |
| $39.37M | 7.22% | |
| $39.34M | 7.42% | |
| $27.57M | 6.11% | |
| $23.33M | 4.40% | |
| $22.89M | 4.32% | |
| $20.84M | 3.93% | |
| $14.92M | 2.74% | |
| $12.23M | 2.31% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Morrell Martha Executive | Sell | Common Stock | $399.3K | -25K -33.35% | 49,964 0.15% of shares | medium |
| Mar 3, 2026 | Becker Joel CEO | Other | Common Stock | $69.5K | -5K -4.93% | 96,937 0.28% of shares | low |
| Feb 20, 2026 | Morrell Martha Executive | Other | Common Stock | $48.9K | -3K -4.33% | 75,322 0.22% of shares | low |
| Mar 20, 2026 | Fischer Frank M Director | Grant | Common Stock | $23.7K | +2K +0.31% | 595,177 1.73% of shares | low |
| Jun 19, 2026 | Fischer Frank M Director | Grant | Common Stock | $22.9K | +1K +0.25% | 599,534 1.75% of shares | low |
| Mar 3, 2026 | Morrell Martha Executive | Other | Common Stock | $18.5K | -1K -2.68% | 48,624 0.14% of shares | low |
| Mar 24, 2026 | Morrell Martha Executive | Other | Common Stock | $17.8K | -1K -2.76% | 47,283 0.14% of shares | low |
| Feb 27, 2026 | Becker Joel CEO | Other | Common Stock | $16.4K | -1K -1.09% | 101,960 0.30% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Orbimed Advisors LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| NPCE | — | 641288105 |